An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread

Columbia University Medical Center (Cumc), New York

Roswell Park Cancer Institute, Buffalo

Fox Chase Cancer Center, Philadelphia

Georgetown University Medical Center, Washington D.C.

Istituto Clinico Humanitas, Rozzano

IRCCS Istituto Nazionale Tumori Milano, Milan

Fundacion Jimenez Diaz, Madrid

Hosp. Univ. Puerta De Hierro, Majadahonda - Madrid

Hospital Universitario Virgen De La Victoria, Málaga

Clinica Universidad de Navarra, Pamplona

Local Institution, Ramat Gan

Local Institution, Tel Aviv

University Of Colorado, Aurora

Providence Portland Medical Center, Portland

Oregon Health & Science University, Portland

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Cross Cancer Institute, Edmonton

Local Institution, Ottawa

Local Institution, Toronto

Local Institution, Amsterdam

Local Institution, Utrecht

H. Univ. Vall dHebron, Barcelona